- Home
- SLXNW vs EXLS Comparison
SLXNW vs EXLS Comparison
Compare SLXNW & EXLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLXNW
- EXLS
- Stock Information
- Founded
- SLXNW N/A
- EXLS 1999
- Country
- SLXNW Israel
- EXLS United States
- Employees
- SLXNW N/A
- EXLS N/A
- Industry
- SLXNW
- EXLS Business Services
- Sector
- SLXNW
- EXLS Consumer Discretionary
- Exchange
- SLXNW Nasdaq
- EXLS Nasdaq
- Market Cap
- SLXNW N/A
- EXLS N/A
- IPO Year
- SLXNW N/A
- EXLS 2006
- Fundamental
- Price
- SLXNW $0.02
- EXLS $44.69
- Analyst Decision
- SLXNW
- EXLS Strong Buy
- Analyst Count
- SLXNW 0
- EXLS 8
- Target Price
- SLXNW N/A
- EXLS $42.25
- AVG Volume (30 Days)
- SLXNW N/A
- EXLS 1.0M
- Earning Date
- SLXNW N/A
- EXLS 10-29-2024
- Dividend Yield
- SLXNW N/A
- EXLS N/A
- EPS Growth
- SLXNW N/A
- EXLS 8.50
- EPS
- SLXNW N/A
- EXLS 1.14
- Revenue
- SLXNW N/A
- EXLS $1,771,004,000.00
- Revenue This Year
- SLXNW N/A
- EXLS $14.68
- Revenue Next Year
- SLXNW N/A
- EXLS $12.46
- P/E Ratio
- SLXNW N/A
- EXLS $39.24
- Revenue Growth
- SLXNW N/A
- EXLS 11.29
- 52 Week Low
- SLXNW N/A
- EXLS $27.53
- 52 Week High
- SLXNW N/A
- EXLS $47.32
- Technical
- Relative Strength Index (RSI)
- SLXNW N/A
- EXLS 64.93
- Support Level
- SLXNW N/A
- EXLS $41.22
- Resistance Level
- SLXNW N/A
- EXLS $47.32
- Average True Range (ATR)
- SLXNW 0.00
- EXLS 1.08
- MACD
- SLXNW 0.00
- EXLS 0.17
- Stochastic Oscillator
- SLXNW 0.00
- EXLS 70.65
About SLXNW Biomotion Sciences Warrant
Silexion Therapeutics Corp is a developmental-stage company dedicated to the development of treatments for pancreatic cancer. The company is focused on enhancing its first-generation product (LODERTM ) to develop a newly formulated product to improve the clinical efficacy against pancreatic cancer.